Pharmacotherapy Specialty Review Course for Recertification, Core Therapeutic Modules + RECERT EXAMS Package (Cert # L209310)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 10/28/2020
Content Release Date: 11/25/2020
Expiration Date: 11/23/2021
Activity Type: Application-based
CE Credits: 21 hours (BPS & ACPE)
Activity Fee: $475 (ASHP member); $675 (non-member)

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Target Audience

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in pharmacotherapy pharmacy.

Activity Overview

This course is intended for BCPS in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS) to provide an overview of recent standards and guidelines that specialists should be familiar with in practice. The course uses a case-based approach to discuss patient care issues. In this series, faculty will:

  • Review pertinent clinical topics and practice skills
  • List valuable resources for further self-study 

This online course consists of 15 activities (see tables below) and provides up to 21 hours of continuing pharmacy education credit.

Recertification Credit*

Board certified pharmacists are eligible to receive up to 21 hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed.  You are allowed only one attempt to successfully complete this assessment.

This course is not intended for those preparing to take the BPS Pharmacotherapy Specialty Examination for Certification. To prepare for the examination, please see courses here: http://elearning.ashp.org/catalog/ptherapy-review

These activities are part of the ASHP professional development program for BCPS recertification approved by the BPS.

* Please note: Review Course for Recertification may only be completed for recertification credit up to two times, in nonconsecutive years, during the 7-year recertification cycle.

Learning Activity

ACPE Number

Credit Hours

Assessment Pass Point

Cardiovascular Disease: Primary Prevention Case

0204-0000-21-932-H01-P

1.50

73%

Cardiovascular Disease: Secondary Prevention Case

0204-0000-21-933-H01-P

1.50

Complex Heart Failure Case

0204-0000-21-934-H01-P

1.50

Providing Safe and Effective Pharmacotherapy: Key Regulatory and Quality Approaches

0204-0000-21-935-H05-P

1.50

Group 1 Assessment 

Research Methods and Data Analysis / Evidence-based Practice and Resources

0204-0000-21-936-H01-P

2.50

72%

Oncology and Supportive Care Case

0204-0000-21-938-H01-P

1.50

Complex Nursing Home Patient Case

0204-0000-21-939-H01-P

1.50

Group 2 Assessment 

Complex HIV Case

0204-0000-21-940-H01-P

1.50

76%

Complex Pediatric Asthma Case

0204-0000-21-941-H01-P

1.50

Complex Pneumonia Case

0204-0000-21-942-H01-P

1.50

Group 3 Assessment 

                                               

Review Course Learning Objectives

After participating in this CPE activity, learners should be able to:

ACPE Number: 0204-0000-21-932-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including hypertension, dyslipidemia, chronic kidney disease, diabetes, and obesity.
  • State the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices recommendations for adult immunizations.
  • Determine how to advise a patient on point-of-care testing to measure response to drug therapy.
  • Discuss national benchmarking standards and implications to patient care.

ACPENumber: 0204-0000-21-933-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including atrial fibrillation (AF), acute coronary syndromes (ACS), and gastroesophageal reflux disease (GERD).
  • Develop a plan to address continuity of care issues.
  • Formulate a medication therapy plan for smoking cessation.
  • Determine how to manage drug – drug and drug-induced disease interactions in a patient with ischemic heart disease.
  • Discuss quality of life in this population.
  • Discuss national benchmarking standards and implications to patient care.

ACPE Number: 0204-0000-21-934-H01-P

  • Select optimal treatment and monitoring for a complex patient-case with multiple conditions, including heart failure, electrolyte disturbances in acute decompensated heart failure, diabetes, and a thyroid disorder.
  • Discuss the medications that should be avoided in heart failure.
  • Identify safety issues in this population.
  • Define inadequate health literacy in this population.

ACPE Number: 0204-0000-21-935-H05-P

  • Explain the regulatory and accreditation  requirements of a comprehensive medication use program.
  • Describe methods to develop and maintain a medication use system.
  • Discuss technology used to promote safe and effective medication use.
  • Apply national regulations and evidence-based practicesfor medication safety and quality.
  • Interpret results from pharmacotherapy-related quality improvement activities.

ACPE Number: 0204-0000-21-936-H04-P

  • Analyze biomedical literature with regard to study methodology, statistical analysis, and significance.
  • Explain the use of evidence-based treatment guidelines and protocols.
  • Interpret the biomedical literature and its application to clinical practice.
  • Identify sources of information to use to answer questions in one’s practice, or from patients and healthcare professionals.
  • Explain how to provide education regarding evidence-based practice to current and future health care professionals.

ACPE Number: 0204-0000-21-938-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including breast cancer, febrile neutropenia and pulmonary embolism.
  • Compare and contrast current breast cancer screening recommendations.
  • Develop a plan to manage pain and nausea/vomiting in a patient with cancer.
  • Discuss safety issues in this population.
  • Discuss adherence issues with oral chemotherapy regimens.

ACPE Number: 0204-0000-21-939-H01-P

  • Select the appropriate treatment for a complex patient-case with multiple conditions, including stroke, depression/anxiety, dementia, chronic obstructive pulmonary disease (COPD) management, osteoarthritis, osteoporosis, and pain.
  • Discuss complimentary/alternative medicine and safety issues in this population.
  • Discuss quality improvement initiatives and regulations in the nursing home setting.

ACPE Number: 0204-0000-21-940-H02-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including dyslipidemia, and hepatitis B.
  • Identify and manage common drug interactions experienced by HIV-treated patients.
  • Identify and manage common adverse drug reactions experienced by HIV-treated patients.
  • Determine appropriate medication choices for the treatment and prevention of common opportunistic infections.
  • Discuss quality of life issues in terms of medication therapy for HIV-infected patients.
  • Identify and recommend appropriate resource organizations/groups to assist a specific patient.

ACPE Number: 0204-0000-21-941-H01-P

  • Select optimal treatment and monitoring for a complex patient-case with acute asthma exacerbation, acute otitis media, and seasonal allergies.
  • Apply methods for counseling a patient and/or caregiver in asthma self-management with comprehensive documentation of patient counseling.
  • Develop a plan for childhood vaccinations in a child who has been delayed in receiving them.
  • Implement principles of shared-decision making and culturally effective care when using complementary/alternative medicine in a pediatric patient.

ACPE Number: 0204-0000-21-942-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including pneumonia, acute renal insufficiency, sepsis, chronic obstructive pulmonary disease (COPD) and dehydration.
  • Interpret clinical data, including lab, physical examination and vital signs.
  • Determine and prioritize pneumonia-related treatment goals.
  • Determine approaches to manage drug allergies and select next best drug therapy when primary drugs are precluded. 
  • Discuss approaches to limiting antimicrobial over use by stewarding antibiotic usage appropriately.
  • Discuss safety issues in patients receiving treatment for pneumonia.

Core Therapeutic Modules

The Core Therapeutic Modules Review Package consists of 15 activities (see table below) and provides up to 16 hours of continuing pharmacy education credit. Faculty review clinical topics and practice skills using a case-based approach. The activities are designed to assist the learner in identifying knowledge gaps in preparation for a pharmacy specialty board examination. In addition to a recorded presentation, each activity includes links to resources for further self-study and a practice test developed in the same format and rigor as the specialty exam.

Learning Module

ACPE Number

Credit Hours

Assessment Pass Point

Cardiac Arrhythmias and Advanced Cardiac Life Support

0204-0000-19-603-H01-P

1.00

75%

Pharmacotherapy Considerations in the Management of Shock

0204-0000-17-931-H01-P

1.00

Select Topics in Men's Health

0204-0000-17-932-H01-P

1.00

Select Topics in Women's Health

0204-0000-18-921-H01-P

1.00

Select Topics in Gastrointestinal Diseases

0204-0000-18-922-H01-P

1.00

  

Core Therapeutic Learning Objectives

Cardiac Arrhythmias and Advanced Cardiac Life Support

ACPE Number: 0204-0000-19-603-H01-P

  • Interpret signs, symptoms and diagnostic tests for cardiac arrhythmias.
  • Identify drug-related problems, including drug interactions and adverse effects, associated with pharmacotherapy of cardiac arrhythmias.
  • Identify and prevent drug-induced cardiac arrhythmias.
  • Determine the most appropriate therapy and monitoring for cardiac arrhythmias based on patient-specific information and the most current guidelines.
  • Utilize advanced cardiac life support (ACLS) guided therapies.
Pharmacotherapy Considerations in the Management of Shock

ACPE Number: 0204-0000-17-931-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Interpret diagnostic and/or laboratory tests, vital signs, and clinical presentation in order to differentiate types of shock (hypovolemic, distributive, cardiogenic).
  • Compare and contrast the pharmacologic agents utilized in shock.
  • Determine the most appropriate therapy and monitoring based on patient-specific information and the most current guidelines for the treatment of shock.
Select Topics in Men's Health

ACPE Number: 0204-0000-17-932-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Identify the role of prostate cancer screening and discuss available options for those requiring treatment.
  • Determine the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines for patients with benign prostatic hyperplasia, erectile dysfunction and testosterone deficiency. 
  • Provide an overview of screening and treatment of osteoporosis in men.
  • Discuss current recommendations for prevention of HIV transmission in high risk patient populations.
Select Topics in Women's Health

ACPE Number: 0204-0000-18-921-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Identify how drug response differs based on sex.
  • Recommend health screenings based on patient-specific information for osteoporosis, breast cancer, endometrial cancer, and cervical cancer.
  • Determine the most appropriate treatment and monitoring based on patient-specific information and the most current guidelines for osteoporosis and menopausal symptoms.
  • Determine which contraceptive options are appropriate based on patient-specific information, including emergency contraception.
  • Recommend safe and effective therapies to use during pregnancy and lactation.
Select Topics in Gastrointestinal Diseases

ACPE Number: 0204-0000-18-922-H01-P

At the conclusion of this application-based educational activity, participants should be able to do the following:

  • For patients with nausea, vomiting, inflammatory bowel disease, gastroesophageal reflux disease or peptic ulcer disease: Determine the most appropriate treatment and monitoring regimen based on drug-specific variables, patient-specific factors, and clinical practice guidelines.
  • Assess available information to identify drug-related problems and response to drug therapy.
  • Identify appropriate modifications to optimize patient-specific treatment plans based on follow-up assessment.

 

Planners, Presenters, and Reviewers

Full Faculty Bios

Christopher Betz, Pharm.D., BCPS, FASHP, FKSHP*
Professor, Department of Clinical and Administrative Sciences
Sullivan University College of Pharmacy
Cardiology Clinical Pharmacy Specialist
Jewish Hospital Rudd Heart and Lung Center
Louisville, Kentucky 
Snehal Bhatt, Pharm.D., BCPS*
Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Science
Clinical Pharmacist
Beth Israel Deaconess Medical Center
Boston, Massachusetts 
Kalin Clifford, Pharm.D., BCPS, BCGP
Assistant Professor of Pharmacy Practice, Geriatrics & Pediatrics Division
Texas Tech University Health Sciences Center School of Pharmacy
Dallas, Texas 
Stuart Haines, Pharm.D., BCPS, BCACP, BC-ADM
Professor and Director, Pharmacy Professional Development
University of Mississippi School of Pharmacy
Jackson, Mississippi
Meredith Keisler, Pharm.D., BCOP, CPP
Clinical Pharmacist Practitioner, Oncology Supportive Care Consult Service
University of North Carolina Healthcare
Hillsborough, North Carolina
Patricia C. Kienle, R.Ph., M.P.A., FASHP
Director, Accreditation and Medication Safety
Cardinal Health Innovative Delivery Systems
Wilkes-Barre, Pennsylvania
Joel Marrs, Pharm.D., BCACP, BCPS-AQ Cardiology, FASHP, FCCP, FNLA
Associate Professor
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Aurora, Colorado
Clinical Pharmacy Specialist
Denver Health Medical Center
Denver, Colorado

Professor and Chair
University of Maryland School of Pharmacy
Baltimore, Maryland

Marc H. Scheetz, Pharm.D., M.S., BCPS-AQ ID
Associate Professor Midwestern University
Downers Grove, Illinois
Infectious Diseases Pharmacist
Northwestern Memorial Hospital
Chicago, Illinois
Douglas Slain, Pharm.D., BCPS, FASHP*
Professor and Infectious Diseases Clinical Specialist
West Virginia University (WVU) and WVU Hospitals and Clinics
Canonsburg, Pennsylvania

*Content matter experts

Reviewers

Anna M. Jackson, Pharm.D., BCPS
Tony Martin, Pharm.D., M.B.A.
Susan R. Dombrowski, M.S., R.Ph.

Field Testers

Sam Abid, Pharm.D., BCPS
Dennis Ankrah, Pharm.D. BCPS
Julie Asmus, Pharm.D., BCPS
Laura Avino, Pharm.D., M.B.A., BCPS
Emma Bingen, Pharm.D.,BCPS
Christopher Brown, Pharm.D., BCPS
Laura Case, Pharm.D., BCPS
Stacy Cassat, M.S., Pharm.D., BCP
Brooklyn Cobb, Pharm.D.
Naomi Digiantonio, Pharm.D., BCPS
Aulbrey Drisaldi, Pharm.D., BCPS
Ian Dunne, Pharm.D., BCPS
Lisa Dykes, Pharm.D., BCPS, BCACP, MHA
Jerilynn Folino, Pharm.D., BCPS
Beth Fritsch, Pharm.D., M.B.A., BCPS
Jillian Fuller, Pharm.D., BCPS
Alfredo Guzman, Pharm.D., BCPS
Jessica Hagy, Pharm.D., BCPS
Christine Hancock, Pharm.D., BCPS
Tatsiana Iannaccio, Pharm.D., BCPS
Marina Ishak, Pharm.D. ,BCPS
Jamie Kneebusch, Pharm.D., BCPS, BCPP
Noelle Kwan, Pharm.D., BCPS
Daisy Leong, Pharm.D., BCPS
John Alex Littler, Pharm.D., BCPS
Chris Mahaffey, Pharm.D., BCPS
Jamie Mahan, Pharm.D., BCPS
Linda McCusker, BSPharm, M.B.A., BCPS
Victoria McWilliams, Pharm.D., BCPS
Darren Mensch, Pharm.D., BCPS, BCACP
Amanda Mullins, Pharm.D., BCPS
Melissa Murphy, Pharm.D., BCPS
Jenny Nelson, Pharm.D., BCPS
Babatunde Ogun, Pharm.D., BCPS
Elizabeth Oladele, Pharm.D., BCPS
Melissa Overmiller, Pharm.D., BCPS
Marie Parish, Pharm.D., BCPS, AAHIVP
Atish Patel, Pharm.D., BCPS
David Petley, Pharm.D., BCPS, BCCCP
Edyta Pilch, Pharm.D., BCPS
Daniel Polchinski, Pharm.D., BCPS
Mitch Purse, Pharm.D., BCPS, DPLA
Emily Richards, Pharm.D., M.B.A., BCPS
Shauna Samuel, Pharm.D., BCPS
Craig Sauers, Pharm.D., BCPS
Garcia Simon-Clarke, Pharm.D, BCNP, BCGP, BCPS
Melanie Sisco, Pharm.D. BCPS
Ashley Stajkowski, Pharm.D., BCPS
Emily Tschumper, Pharm.D., M.S., BCPS
Tyler Vest, Pharm.D., M.S., BCPS, BCSCP
Marisa Zweifel, Pharm.D., BCPS

Faculty

Clinical Pharmacy Specialist - Medical Oncology
Emory Healthcare - Winship Cancer Institute
Atlanta, Georgia
Associate Professor of Pharmacy Practice, Division of Geriatrics and Pediatrics
Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy
Clinical Pharmacy Specialists, Geriatrics & Extended Care
VA North Texas Health Care System
Dallas, Texas
Assistant Professor of Clinical Pharmacy
Philadelphia College of Pharmacy, University of the Sciences
Philadelphia, Pennsylvania
Clinical Pharmacy Specialist - Ambulatory Care
Cooper University Hospital
Camden, New Jersey
Clinical Specialist, Emergency Medicine
Mercy Health Saint Mary's
Grand Rapids, Michigan
Assistant Clinical Professor
Auburn University Harrison School of Pharmacy
Tuscaloosa, Alabama

Clinical Pharmacy Practice Manager
Brigham & Women's Hospital
Boston, Massachusetts

Content Matter Experts

Professor
Sullivan University College of Pharmacy & Health Sciences
Cardiology Clinical Pharmacy Specialist
Jewish Hospital Rudd Heart and Lung Center – U of L Health
Louisville, Kentucky
Professor of Pharmacy Practice
MCPHS University School of Pharmacy - Boston
Clinical Pharmacist
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Associate Professor of Clinical Pharmacy, PGY2 Critical Care Pharmacy Residency Program Director
Philadelphia College of Pharmacy, University of the Sciences
Philadelphia, Pennsylvania
Critical Care Clinical Pharmacy Specialist
Cooper University Hospital
Camden, New Jersey
Associate Dean
Professor, Pharmacy Practice
Jefferson College of Pharmacy
Philadelphia, Pennsylvania
Professor and Infectious Diseases Clinical Specialist
West Virginia University
Morgantown, West Virginia

Reviewers

Anna M. Jackson, Pharm.D., BCPS
Tony Martin, Pharm.D., M.B.A.
Susan R. Dombrowski, M.S., R.Ph.

Field Testers

Merlin Alexander, Pharm.D., BCPS
Macayla Bartucca, Pharm.D.
Sarah Benner, Pharm.D., BCPS, BCPP
Zachary Brent, Pharm.D., BCPS
Heng Chang, Pharm.D., BCPS
Judy Chennat, Pharm.D, BCPS
Diana Cowell, Pharm.D., BCPS
Lydia D'Agostino, Pharm.D., BCPS, BCIDP
Tara Driscoll, Pharm.D., BCPS, BCACP
Tara Feller, Pharm.D., M.B.A., MPH, BCPS
Kisha Gant, Pharm.D., BCACP, BCGP, BCPS
Catlin Grisham-Takac, Pharm.D., BCPS
Laura Hart, Pharm.D., M.S., BCPS, BCGP
Michele Havens, Pharm.D, BCPS
Elham Hekmat, Pharm.D., BCPS
Lindsey Hunt, Pharm.D., BCPS
Kimberly Johnson, Pharm.D.,BCPS
claire kestenbaum, Pharm. D., BCPS
Serena Key-Tate, Pharm.D., BCPS, BCSCP
jessen Koshy, Pharm.D. BCPS
Lauren Leedom, BS,BCPS,M.B.A.
Areerut Leelathanalerk, Pharm.D., BCPS
Jamie Longmire, Pharm.D., BCPS
Laura MacCall, Pharm.D., BCPS
Melanie Madorsky, Pharm.D., BCPS, BCCP
Chinwe Mbonu, Pharm.D., BCPS
Mallory McCullough, Pharm.D., BCPS
Scott McDougall, Bsc Pharm, BCPS
Michael McQuade, Pharm.D., BCCCP, BCPS
Amanda McQuillan, Pharm.D., BCPS, BCPP
Sarah Michienzi, Pharm.D., BCPS, AAHIVP
Ana Miladinovic, Pharm.D.,BCPS
Jessica Moschea, Pharm.D., BCPS
Ijang Ngando, Pharm.D., M.B.A., BCPS, BCCCP
Ramat Aderemi Omole, Pharm D., M.Sc., BCPS, CPH
Liz Palmer, Pharm.D., BCPS
Nisha Patel, Pharm.D., M.B.A., BCPS
Kerry Anne Rambaran, Pharm.D., BCPS
Mohammad Rattu, Pharm.D., BCOP, BCPS, BCGP
Heather Redden, Pharm.D.
Amy Richardson, Pharm.D., BCPS
Brooke Roe, Pharm.D.
Hollins Schwantes, Pharm.D., BCCCP, BCPS
Gita Soltani, Pharm D
Conner Sothoron, Pharm.D.., BCPS, BCCCP
Stacia Street, Pharm.D., BCPS
Marisa Strychalski, Pharm.D., BCPS, BCACP
Florence Tan, Pharm.D., BCPS, BCGP
Alison Tonsk, Pharm.D., BCPS, BCGP
Aiwen Wang, Pharm.D.
Corrie Weiland, Pharm.D., BCPS
Max Whitney, Pharm.D., BCCCP, BCPS
Robert Wood, Pharm.D., BCPS
Kelsie Young, Pharm.D.,BCPS

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

  • Snehal Bhatt, Pharm.D., BCPS, Amgen, Stockholder; Portola Pharmaceuticals - Advisory Board; Janssen Pharmaceuticals, Inc. - Speaker Bureau

All other planners, presenters, and reviewers of this session report no financial relationships relevant to this activity.

Methods and CE Requirements

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

System Technical Requirements

Learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites.

View the minimum technical and system requirements for learning activities.

Development

These activities were developed by ASHP.

To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for Board Certification Examinations.